Bioasis Technologies Inc. (BIOAF)

OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0002 (-99.50%)
At close: Nov 10, 2025
0.00%
Market Cap 79.00
Revenue (ttm) 199.01K
Net Income (ttm) -2.12M
Shares Out 79.41M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,541
Average Volume 14,766
Open 0.0000
Previous Close 0.0002
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0006
Beta 86.99
RSI 42.33
Earnings Date n/a

About Bioasis Technologies

Bioasis Technologies Inc. operates as a biopharmaceutical company. The company utilizes its proprietary xB3 platform to deliver therapeutics across the blood-brain barrier and treat central nervous system disorders in areas of high unmet medical need. Bioasis Technologies Inc. is based in New Haven, Connecticut. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol BIOAF
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

There is no news available yet.